Old Web
English
Sign In
Acemap
>
authorDetail
>
Jiajia Mai
Jiajia Mai
Jilin University
Medicine
Internal medicine
Tolerability
Pharmacokinetics
Placebo
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers.
2021
Expert Opinion on Investigational Drugs
Yue Hu
Hong Zhang
Xiaojiao Li
Jiajia Mai
Lizhi Yang
Jie Yan
Ying Li
Jingchao Sun
Wenjie Xu
Shiying He
Jinfeng Li
Min Wu
Show All
Source
Cite
Save
Citations (0)
A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects.
2021
European Journal of Pharmaceutical Sciences
Cuiyun Li
Wei Xiang
Min Wu
Hong Zhang
Jianqiu Cheng
Tao Yang
Jiajia Mai
Xiumei Chi
Xiuzhu Gao
Yanhua Ding
Junqi Niu
Show All
Source
Cite
Save
Citations (0)
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial.
2021
Antimicrobial Agents and Chemotherapy
Cuiyun Li
Min Wu
Hong Zhang
Jiajia Mai
Lizhi Yang
Yanhua Ding
Junqi Niu
John Mao
Wenqiang Wu
Dong Zhang
Yanan Tang
Wenhao Yan
Show All
Source
Cite
Save
Citations (1)
1